nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—nephrolithiasis	0.465	1	CbGaD
Acetazolamide—CA5B—Hydrochlorothiazide—nephrolithiasis	0.0838	0.191	CbGbCtD
Acetazolamide—CA9—Hydrochlorothiazide—nephrolithiasis	0.0719	0.164	CbGbCtD
Acetazolamide—CA12—Hydrochlorothiazide—nephrolithiasis	0.0719	0.164	CbGbCtD
Acetazolamide—CA1—Hydrochlorothiazide—nephrolithiasis	0.0673	0.153	CbGbCtD
Acetazolamide—CA4—Hydrochlorothiazide—nephrolithiasis	0.0632	0.144	CbGbCtD
Acetazolamide—CA2—Hydrochlorothiazide—nephrolithiasis	0.0581	0.133	CbGbCtD
Acetazolamide—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.0224	0.051	CbGbCtD
Acetazolamide—AQP1—collecting duct of renal tubule—nephrolithiasis	0.0131	0.321	CbGeAlD
Acetazolamide—AQP1—nephron—nephrolithiasis	0.00583	0.143	CbGeAlD
Acetazolamide—AQP1—urine—nephrolithiasis	0.00468	0.115	CbGeAlD
Acetazolamide—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.00384	0.122	CbGpPWpGaD
Acetazolamide—CA2—collecting duct of renal tubule—nephrolithiasis	0.00349	0.0856	CbGeAlD
Acetazolamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00328	0.104	CbGpPWpGaD
Acetazolamide—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00314	0.0998	CbGpPWpGaD
Acetazolamide—CA1—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00301	0.0957	CbGpPWpGaD
Acetazolamide—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.00225	0.0927	CcSEcCtD
Acetazolamide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.00179	0.0568	CbGpPWpGaD
Acetazolamide—AQP1—nephron tubule—nephrolithiasis	0.00126	0.0308	CbGeAlD
Acetazolamide—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0478	CcSEcCtD
Acetazolamide—AQP1—renal system—nephrolithiasis	0.00114	0.028	CbGeAlD
Acetazolamide—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00113	0.0467	CcSEcCtD
Acetazolamide—AQP1—kidney—nephrolithiasis	0.00111	0.0271	CbGeAlD
Acetazolamide—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00108	0.0447	CcSEcCtD
Acetazolamide—AQP1—cortex of kidney—nephrolithiasis	0.00108	0.0264	CbGeAlD
Acetazolamide—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00107	0.0441	CcSEcCtD
Acetazolamide—CA7—renal system—nephrolithiasis	0.000915	0.0224	CbGeAlD
Acetazolamide—CA7—kidney—nephrolithiasis	0.000884	0.0217	CbGeAlD
Acetazolamide—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.000882	0.0363	CcSEcCtD
Acetazolamide—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.000849	0.035	CcSEcCtD
Acetazolamide—CYP3A4—urine—nephrolithiasis	0.000805	0.0197	CbGeAlD
Acetazolamide—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.000776	0.032	CcSEcCtD
Acetazolamide—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.000776	0.032	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000736	0.0233	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000736	0.0233	CbGpPWpGaD
Acetazolamide—SLC22A6—nephron tubule—nephrolithiasis	0.00073	0.0179	CbGeAlD
Acetazolamide—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000716	0.0295	CcSEcCtD
Acetazolamide—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000685	0.0282	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000656	0.0208	CbGpPWpGaD
Acetazolamide—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.000641	0.0264	CcSEcCtD
Acetazolamide—SLC22A6—cortex of kidney—nephrolithiasis	0.000625	0.0153	CbGeAlD
Acetazolamide—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00062	0.0256	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.000614	0.0253	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0006	0.019	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0006	0.019	CbGpPWpGaD
Acetazolamide—CA12—renal system—nephrolithiasis	0.000594	0.0146	CbGeAlD
Acetazolamide—CA12—kidney—nephrolithiasis	0.000575	0.0141	CbGeAlD
Acetazolamide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000538	0.0222	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.000521	0.0215	CcSEcCtD
Acetazolamide—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000501	0.0206	CcSEcCtD
Acetazolamide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00049	0.0202	CcSEcCtD
Acetazolamide—CA1—renal system—nephrolithiasis	0.000471	0.0115	CbGeAlD
Acetazolamide—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000469	0.0193	CcSEcCtD
Acetazolamide—CA1—kidney—nephrolithiasis	0.000455	0.0111	CbGeAlD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000454	0.0144	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000454	0.0144	CbGpPWpGaD
Acetazolamide—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000446	0.0184	CcSEcCtD
Acetazolamide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00044	0.0181	CcSEcCtD
Acetazolamide—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000438	0.018	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000423	0.0134	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000423	0.0134	CbGpPWpGaD
Acetazolamide—CA4—nephron tubule—nephrolithiasis	0.000405	0.00991	CbGeAlD
Acetazolamide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000402	0.0166	CcSEcCtD
Acetazolamide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000381	0.0157	CcSEcCtD
Acetazolamide—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000377	0.0155	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000377	0.0119	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000377	0.0119	CbGpPWpGaD
Acetazolamide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00037	0.0153	CcSEcCtD
Acetazolamide—CA4—renal system—nephrolithiasis	0.000368	0.00901	CbGeAlD
Acetazolamide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000368	0.0151	CcSEcCtD
Acetazolamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000358	0.0114	CbGpPWpGaD
Acetazolamide—CA4—kidney—nephrolithiasis	0.000356	0.00871	CbGeAlD
Acetazolamide—CA4—cortex of kidney—nephrolithiasis	0.000346	0.00849	CbGeAlD
Acetazolamide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000345	0.0142	CcSEcCtD
Acetazolamide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000338	0.0139	CcSEcCtD
Acetazolamide—CA2—nephron tubule—nephrolithiasis	0.000336	0.00822	CbGeAlD
Acetazolamide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000335	0.0138	CcSEcCtD
Acetazolamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000333	0.0106	CbGpPWpGaD
Acetazolamide—Shock—Hydrochlorothiazide—nephrolithiasis	0.00033	0.0136	CcSEcCtD
Acetazolamide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000328	0.0135	CcSEcCtD
Acetazolamide—CA2—renal system—nephrolithiasis	0.000305	0.00747	CbGeAlD
Acetazolamide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000301	0.0124	CcSEcCtD
Acetazolamide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000298	0.0123	CcSEcCtD
Acetazolamide—CA2—kidney—nephrolithiasis	0.000295	0.00722	CbGeAlD
Acetazolamide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000295	0.0122	CcSEcCtD
Acetazolamide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000291	0.012	CcSEcCtD
Acetazolamide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000289	0.0119	CcSEcCtD
Acetazolamide—CA2—cortex of kidney—nephrolithiasis	0.000287	0.00704	CbGeAlD
Acetazolamide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000276	0.0114	CcSEcCtD
Acetazolamide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000266	0.011	CcSEcCtD
Acetazolamide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000265	0.0109	CcSEcCtD
Acetazolamide—AQP1—Metabolism—GRHPR—nephrolithiasis	0.000261	0.00829	CbGpPWpGaD
Acetazolamide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00024	0.00991	CcSEcCtD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000235	0.00745	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AGXT—nephrolithiasis	0.000233	0.00739	CbGpPWpGaD
Acetazolamide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000229	0.00945	CcSEcCtD
Acetazolamide—CA3—Metabolism—GRHPR—nephrolithiasis	0.000226	0.00718	CbGpPWpGaD
Acetazolamide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000222	0.00913	CcSEcCtD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000215	0.00682	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000215	0.00682	CbGpPWpGaD
Acetazolamide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000213	0.00878	CcSEcCtD
Acetazolamide—Headache—Hydrochlorothiazide—nephrolithiasis	0.00021	0.00865	CcSEcCtD
Acetazolamide—CA3—Metabolism—AGXT—nephrolithiasis	0.000202	0.0064	CbGpPWpGaD
Acetazolamide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000199	0.0082	CcSEcCtD
Acetazolamide—AQP1—Metabolism—APRT—nephrolithiasis	0.000198	0.00628	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—SLC26A1—nephrolithiasis	0.000198	0.00628	CbGpPWpGaD
Acetazolamide—CYP3A4—renal system—nephrolithiasis	0.000197	0.00482	CbGeAlD
Acetazolamide—CYP3A4—kidney—nephrolithiasis	0.00019	0.00466	CbGeAlD
Acetazolamide—CA3—Metabolism—APRT—nephrolithiasis	0.000172	0.00544	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—SLC26A1—nephrolithiasis	0.000172	0.00544	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000163	0.00517	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000163	0.00517	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000151	0.0048	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000151	0.0048	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GRHPR—nephrolithiasis	0.000146	0.00463	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GRHPR—nephrolithiasis	0.000142	0.00451	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GRHPR—nephrolithiasis	0.000142	0.00451	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000135	0.00428	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000134	0.00425	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000134	0.00425	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GRHPR—nephrolithiasis	0.000133	0.00421	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GRHPR—nephrolithiasis	0.000133	0.00421	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AGXT—nephrolithiasis	0.00013	0.00413	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CHRM3—nephrolithiasis	0.000128	0.00405	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AGXT—nephrolithiasis	0.000127	0.00402	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AGXT—nephrolithiasis	0.000127	0.00402	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GRHPR—nephrolithiasis	0.000123	0.0039	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AQP1—nephrolithiasis	0.000122	0.00388	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000119	0.00379	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AGXT—nephrolithiasis	0.000118	0.00375	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AGXT—nephrolithiasis	0.000118	0.00375	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—APRT—nephrolithiasis	0.000111	0.00351	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SLC26A1—nephrolithiasis	0.000111	0.00351	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CHRM3—nephrolithiasis	0.000111	0.00351	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AGXT—nephrolithiasis	0.00011	0.00348	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000109	0.00346	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000109	0.00346	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—APRT—nephrolithiasis	0.000108	0.00342	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SLC26A1—nephrolithiasis	0.000108	0.00342	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SLC26A1—nephrolithiasis	0.000108	0.00342	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—APRT—nephrolithiasis	0.000108	0.00342	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APRT—nephrolithiasis	0.000101	0.00319	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APRT—nephrolithiasis	0.000101	0.00319	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC26A1—nephrolithiasis	0.000101	0.00319	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC26A1—nephrolithiasis	0.000101	0.00319	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GRHPR—nephrolithiasis	9.81e-05	0.00311	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GRHPR—nephrolithiasis	9.4e-05	0.00298	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APRT—nephrolithiasis	9.32e-05	0.00296	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC26A1—nephrolithiasis	9.32e-05	0.00296	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GRHPR—nephrolithiasis	9.01e-05	0.00286	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AGXT—nephrolithiasis	8.74e-05	0.00277	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AGXT—nephrolithiasis	8.38e-05	0.00266	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	8.27e-05	0.00263	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	8.27e-05	0.00263	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AGXT—nephrolithiasis	8.03e-05	0.00255	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GRHPR—nephrolithiasis	7.92e-05	0.00251	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AQP1—nephrolithiasis	7.88e-05	0.0025	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	7.69e-05	0.00244	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	7.69e-05	0.00244	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AQP1—nephrolithiasis	7.68e-05	0.00244	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AQP1—nephrolithiasis	7.68e-05	0.00244	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APRT—nephrolithiasis	7.43e-05	0.00236	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC26A1—nephrolithiasis	7.43e-05	0.00236	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AQP1—nephrolithiasis	7.17e-05	0.00227	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AQP1—nephrolithiasis	7.17e-05	0.00227	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC26A1—nephrolithiasis	7.12e-05	0.00226	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CHRM3—nephrolithiasis	7.12e-05	0.00226	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APRT—nephrolithiasis	7.12e-05	0.00226	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AGXT—nephrolithiasis	7.06e-05	0.00224	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CHRM3—nephrolithiasis	6.94e-05	0.0022	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CHRM3—nephrolithiasis	6.94e-05	0.0022	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	6.86e-05	0.00218	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	6.86e-05	0.00218	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APRT—nephrolithiasis	6.83e-05	0.00217	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC26A1—nephrolithiasis	6.83e-05	0.00217	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AQP1—nephrolithiasis	6.64e-05	0.00211	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CHRM3—nephrolithiasis	6.48e-05	0.00206	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CHRM3—nephrolithiasis	6.48e-05	0.00206	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC26A1—nephrolithiasis	6.01e-05	0.00191	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APRT—nephrolithiasis	6.01e-05	0.00191	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CHRM3—nephrolithiasis	6.01e-05	0.00191	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	5.91e-05	0.00188	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	5.48e-05	0.00174	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AQP1—nephrolithiasis	5.3e-05	0.00168	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AQP1—nephrolithiasis	5.08e-05	0.00161	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AQP1—nephrolithiasis	4.87e-05	0.00154	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CHRM3—nephrolithiasis	4.79e-05	0.00152	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CHRM3—nephrolithiasis	4.59e-05	0.00146	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CHRM3—nephrolithiasis	4.4e-05	0.0014	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AQP1—nephrolithiasis	4.28e-05	0.00136	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CHRM3—nephrolithiasis	3.87e-05	0.00123	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GRHPR—nephrolithiasis	1.33e-05	0.000423	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AGXT—nephrolithiasis	1.19e-05	0.000377	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	1.01e-05	0.000321	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APRT—nephrolithiasis	1.01e-05	0.000321	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AQP1—nephrolithiasis	7.2e-06	0.000229	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CHRM3—nephrolithiasis	6.51e-06	0.000207	CbGpPWpGaD
